Beta-mannosidosis
(Redirected from Lysosomal beta-mannosidase deficiency)
Beta-mannosidosis | |
---|---|
Synonyms | Beta-mannosidase deficiency |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Intellectual disability, hearing loss, recurrent infections, dysostosis multiplex, angiokeratoma |
Complications | N/A |
Onset | Infancy or childhood |
Duration | Lifelong |
Types | N/A |
Causes | Mutations in the MANBA gene |
Risks | Autosomal recessive inheritance |
Diagnosis | Genetic testing, enzyme assay |
Differential diagnosis | Other lysosomal storage disorders |
Prevention | N/A |
Treatment | Supportive care, symptomatic treatment |
Medication | N/A |
Prognosis | Variable, depends on severity |
Frequency | Rare |
Deaths | N/A |
A rare genetic disorder affecting glycoprotein metabolism
Beta-mannosidosis is a rare lysosomal storage disorder caused by a deficiency of the enzyme beta-mannosidase. This enzyme deficiency leads to the accumulation of mannose-containing oligosaccharides in the body, resulting in a variety of clinical symptoms.
Pathophysiology[edit | edit source]
Beta-mannosidosis is an autosomal recessive disorder, meaning that an individual must inherit two copies of the defective gene, one from each parent, to manifest the disease. The condition is caused by mutations in the MANBA gene, which encodes the enzyme beta-mannosidase. This enzyme is responsible for breaking down complex sugars in the lysosome, a cellular organelle involved in the degradation of macromolecules. In individuals with beta-mannosidosis, the lack of functional beta-mannosidase leads to the accumulation of mannose-rich oligosaccharides in various tissues, including the central nervous system, kidneys, and liver. This accumulation disrupts normal cellular function and leads to the clinical manifestations of the disease.
Clinical Features[edit | edit source]
The symptoms of beta-mannosidosis can vary widely among affected individuals, but common features include:
- Intellectual disability
- Hearing loss
- Speech delay
- Motor dysfunction
- Recurrent infections
- Skeletal abnormalities
The severity of symptoms can range from mild to severe, and the age of onset can vary from infancy to adulthood.
Diagnosis[edit | edit source]
Diagnosis of beta-mannosidosis is typically based on clinical evaluation, biochemical testing, and genetic analysis. Biochemical testing involves measuring the activity of beta-mannosidase in leukocytes or fibroblasts. Genetic testing can confirm the diagnosis by identifying mutations in the MANBA gene.
Treatment[edit | edit source]
Currently, there is no cure for beta-mannosidosis, and treatment is primarily supportive and symptomatic. Management may include:
- Physical therapy and occupational therapy to improve motor skills
- Speech therapy to address communication difficulties
- Hearing aids or other interventions for hearing loss
- Regular monitoring and treatment of infections
Research into potential therapies, such as enzyme replacement therapy and gene therapy, is ongoing.
Prognosis[edit | edit source]
The prognosis for individuals with beta-mannosidosis varies depending on the severity of the condition. Some individuals may lead relatively normal lives with appropriate supportive care, while others may experience significant disability.
Related pages[edit | edit source]
Transform your life with W8MD's budget GLP1 injections from $125
W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.
Why choose W8MD?
- Comprehensive care with FDA-approved weight loss medications including:
- loss injections in NYC both generic and brand names:
- weight loss medications including Phentermine, Qsymia, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
- Budget GLP1 weight loss injections in NYC starting from $125.00 biweekly with insurance!
Book Your Appointment
Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD